menu search

CC / Chemours, DuPont and Corteva reach agreement to settle PFAS-related drinking water claims, but deny allegations

Chemours, DuPont and Corteva reach agreement to settle PFAS-related drinking water claims, but deny allegations
The Chemours Co. CC, +2.34%, DuPont de Nemours Inc. DD, +0.37% and Corteva Inc. CTVA, +0.69% announced Friday an “agreement in principle” to settle all drinking water claims related to perfluoroalkyl and polyfluoroalkyl substances, known as PFAS. “The companies deny the allegations in the underlying litigation and reserve all legal and factual defenses against such claims if they were litigated to conclusion,” the companies said in a statement. Read More
Posted: Jun 2 2023, 06:43
Author Name: Market Watch
Views: 102052

CC News  

The Chemours Company (CC) Q3 2023 Earnings Call Transcript

By Seeking Alpha
October 27, 2023

The Chemours Company (CC) Q3 2023 Earnings Call Transcript

The Chemours Company (NYSE:CC ) Q3 2023 Earnings Conference Call October 27, 2023 8:00 AM ET Company Participants Brandon Ontjes - Vice President of F more_horizontal

Compared to Estimates, Chemours (CC) Q3 Earnings: A Look at Key Metrics

By Zacks Investment Research
October 26, 2023

Compared to Estimates, Chemours (CC) Q3 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended September 2023, it could be w more_horizontal

Why Chemours (CC) Could Beat Earnings Estimates Again

By Zacks Investment Research
October 23, 2023

Why Chemours (CC) Could Beat Earnings Estimates Again

Chemours (CC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat i more_horizontal

Chemours Announces Dates for Third Quarter 2023 Earnings Release and Webcast Conference Call

By Business Wire
October 6, 2023

Chemours Announces Dates for Third Quarter 2023 Earnings Release and Webcast Conference Call

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Third Quarter 2023 Earnings Release and Webcast Conference Call. more_horizontal

Here's Why You Should Hold Onto Chemours (CC) Stock For Now

By Zacks Investment Research
September 27, 2023

Here's Why You Should Hold Onto Chemours (CC) Stock For Now

Chemours (CC) gains on strong execution, continued Opteon adoption and its efforts to reduce costs amid headwinds from demand weakness. more_horizontal

Dutch court rules Chemours liable for environmental damage caused by PFAS

By Reuters
September 27, 2023

Dutch court rules Chemours liable for environmental damage caused by PFAS

U.S. chemical company Chemours CC.N is liable for environmental damage in the Netherlands caused by PFAS chemicals, the Rotterdam District Court ruled more_horizontal

Chemours (CC) Benefits From Opteon Adoption Amid Demand Woes

By Zacks Investment Research
August 31, 2023

Chemours (CC) Benefits From Opteon Adoption Amid Demand Woes

Although Chemours (CC) is being challenged by softer demand in certain businesses, it gains on continued Opteon adoption, strong execution and its cos more_horizontal

Here's Why You Should Retain Chemours (CC) in Your Portfolio

By Zacks Investment Research
August 22, 2023

Here's Why You Should Retain Chemours (CC) in Your Portfolio

While Chemours (CC) is exposed to headwinds from demand softness in certain areas, it gains on continued Opteon adoption, strong execution and its cos more_horizontal


Search within

Pages Search Results: